Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$4.3 - $8.03 $32,219 - $60,168
-7,493 Reduced 22.21%
26,245 $134,000
Q1 2024

Apr 09, 2024

BUY
$6.35 - $9.39 $26,670 - $39,438
4,200 Added 14.22%
33,738 $236,000
Q4 2023

Jan 04, 2024

SELL
$5.59 - $9.55 $46,268 - $79,045
-8,277 Reduced 21.89%
29,538 $261,000
Q3 2023

Oct 10, 2023

BUY
$9.5 - $15.07 $241,575 - $383,215
25,429 Added 205.3%
37,815 $360,000
Q2 2023

Jul 06, 2023

BUY
$11.41 - $17.05 $141,324 - $211,181
12,386 New
12,386 $181,000

Others Institutions Holding PRME

About Prime Medicine, Inc.


  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $386M
More about PRME
Track This Portfolio

Track Green Alpha Advisors, LLC Portfolio

Follow Green Alpha Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Green Alpha Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Green Alpha Advisors, LLC with notifications on news.